Heron Therapeutics (HRTX) Retained Earnings (2010 - 2026)
Heron Therapeutics' (HRTX) quarterly Retained Earnings came in at -$1.9 billion in Q1 2026, down 194790100.0% YoY from N/an in Q1 2025, and little changed on a QoQ basis from -$1.9 billion in Q4 2025.
Heron Therapeutics (HRTX) Retained Earnings (2010 - 2026) Analysis & Trends
Heron Therapeutics (HRTX) has 17 years of Retained Earnings data on file, last reported at -$1.9 billion in Q1 2026.
- Quarterly Retained Earnings fell 194790100.0% year-over-year to -$1.9 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.9 billion (down 194790100.0% YoY) and the FY2025 annual result came in at -$1.9 billion, down 1.05% from the prior year.
- Retained Earnings was little changed at -$1.9 billion in Q1 2026, from -$1.9 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $1.9 billion in Q1 2024 to a low of -$1.9 billion in Q1 2026.
- A 5-year average of -$458.4 million and a median of -$57000.0 in 2022 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2023 — Retained Earnings jumped 9844968.42% — and 2026, when it sank 194790100.0%.
- Tracing HRTX's Retained Earnings over 5 years: stood at -$19000.0 in 2022, then jumped by 9844968.42% to $1.9 billion in 2023, then sank by 202.62% to -$1.9 billion in 2024, then fell by 1.05% to -$1.9 billion in 2025, then fell by 0.42% to -$1.9 billion in 2026.
- The last three Retained Earnings figures came in at -$1.9 billion (Q1 2026), -$1.9 billion (Q4 2025), and -$1.9 billion (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.07 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.92 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 58.86 Bn | 53.72 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 27.88 Bn | 9.49 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - | 4.38 Bn |
| 10 | Heron Therapeutics | 60.87 Mn | 18.21 Mn | 26.09 Mn | 1.96 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.96 Bn |
| Mar 31, 2026 | -1.95 Bn |
| Dec 31, 2025 | -1.94 Bn |
| Sep 30, 2025 | -1.94 Bn |
| Jun 30, 2025 | -1,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Dec 31, 2024 | -1.92 Bn |
| Sep 30, 2024 | -1.92 Bn |
| Jun 30, 2024 | -1.92 Bn |
| Mar 31, 2024 | 1.87 Bn |
| Dec 31, 2023 | 1.87 Bn |
| Sep 30, 2023 | 1.87 Bn |
| Jun 30, 2023 | -6,000.00 |
| Mar 31, 2023 | -1.83 Bn |
| Dec 31, 2022 | -19,000.00 |
| Sep 30, 2022 | -57,000.00 |
| Jun 30, 2022 | 1.71 Bn |
| Mar 31, 2022 | -1.70 Bn |
| Dec 31, 2021 | -6,000.00 |
| Sep 30, 2021 | -1.56 Bn |